PrimeRFP SCOUT · Federal Contract Recompete Brief

HT941023P2070Quantiative next-gen sequencing TEST — Karius Inc

Karius Inc holds $905K across 12 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Defense Health Agency

Awarding office

Karius Inc

Recipient

Sep 30, 2026

PoP end

$60K

Obligated

$240K

Potential

621511

NAICS

Q301

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Karius Inc — $90

Contract facts

NONE

Contract numberHT941023P2070

Also listed asHT9410-23-P-2070

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentKarius Inc

CAGE7WYY2

UEIP6PSJPZLEEG2

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationHT941023Q2058

PoP startOct 1, 2023

PoP end (current)Sep 30, 2026

PoP end (w/ options)Sep 30, 2027

Obligated$60K

Current value$180K

Potential value$240K

QUANTIATIVE NEXT-GEN SEQUENCING TEST is a federal NONE award for Defense Health Agency held by Karius Inc. Estimated value $240K ($60K obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2027). Last award drew 1 bidder. Place of performance: SAN DIEGO CA. Related solicitation HT941023Q2058.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Karius Inc — $905K obligated across 12 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($905K) · all agencies

Department of Health and Human Services (HHS)$755K · 83%Department of Defense (DOD)$98K · 11%Department of Veterans Affairs (VA)$52K · 6%

Open full company profile →

Related awards

Same incumbent

36C24822N0772

KARIUS LABORATORY TESTS FOR THE ORLANDO VAMC.

$120K

Jul 31, 2027

36C24826N0510

KARIUS NEXT GENERATION SEQUENCING TEST $2,000.00 PER TEST

$120K

Jul 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT941023P2070?

HT941023P2070 (Quantiative next-gen sequencing TEST) is a Defense Health Agency award with a potential value of $240K, currently held by Karius Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9410-23-P-2070?

HT9410-23-P-2070 is the dashed form of PIID HT941023P2070 (Quantiative next-gen sequencing TEST), held by Karius Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT941023P2070?

Defense Health Agency awarded HT941023P2070 to Karius Inc (potential $240K).

Who is the incumbent on HT941023P2070?

Karius Inc is the incumbent with $905K across 12 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Karius Inc’s HT941023P2070 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jun 26, 2025